Literature DB >> 20483576

Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD).

Takafumi Suda1, Masato Kono, Yutaro Nakamura, Noriyuki Enomoto, Yusuke Kaida, Tomoyuki Fujisawa, Shiro Imokawa, Kazumasa Yasuda, Hideo Hashizume, Koushi Yokomura, Mikio Toyoshima, Naoki Koshimizu, Hideki Suganuma, Toshihiro Shirai, Dai Hashimoto, Naoki Inui, Thomas V Colby, Kingo Chida.   

Abstract

BACKGROUND: Although idiopathic nonspecific interstitial pneumonia (NSIP) was initially identified as a provisional diagnosis, the 2008 American Thoracic Society Project concluded that idiopathic NSIP is a distinct form of idiopathic interstitial pneumonia. However, an association between idiopathic NSIP and autoimmune diseases still attracts interest. In this context, a recent study proposed an intriguing concept that idiopathic NSIP is the pulmonary manifestation of undifferentiated connective tissue disease (UCTD). However, this has not been confirmed in a large number of patients with idiopathic NSIP. The present study was conducted to investigate the proportion and characteristics of patients with idiopathic NSIP who meet the criteria for UCTD.
METHODS: We reviewed 47 consecutive patients with idiopathic NSIP and examined whether they met prespecified criteria for UCTD. Furthermore, we compared the clinical characteristics between patients fulfilling the UCTD criteria (UCTD-NSIP) and those not meeting them (Non-UCTD-NSIP).
RESULTS: Of 47 patients with idiopathic NSIP, 22 (47%) met the UCTD criteria. Common symptoms associated with connective tissue diseases (CTDs) were skin change (50%) and Raynaud's phenomenon (41%) in UCTD-NSIP. UCTD-NSIP showed a female predominance and significantly higher percentages of lymphocytes with a lower CD4/CD8 ratio in bronchoalveolar lavage than Non-UCTD-NSIP. Interestingly, UCTD-NSIP had a significantly better survival than Non-UCTD-NSIP.
CONCLUSIONS: Idiopathic NSIP included subjects who fulfilled the UCTD criteria, and these subjects had different clinical characteristics with significantly better outcome than those who did not meet the criteria. These data suggest that a part, but not all, of patients with idiopathic NSIP show CTD-like features with a distinct prognosis.

Entities:  

Mesh:

Year:  2010        PMID: 20483576     DOI: 10.1016/j.rmed.2010.04.022

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  18 in total

1.  [Acute on chronic respiratory failure in interstitial pneumonias].

Authors:  M Westhoff
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-08-16       Impact factor: 0.840

2.  Autoimmune-featured interstitial lung disease: a distinct entity.

Authors:  Rekha Vij; Imre Noth; Mary E Strek
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

Review 3.  Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: case report and review of literature.

Authors:  Francesca Lunardi; Elisabetta Balestro; Beatrice Nordio; Franco Cozzi; Roberta Polverosi; Paolo Sfriso; Fausto Braccioni; Fiorella Calabrese
Journal:  Diagn Pathol       Date:  2011-06-07       Impact factor: 2.644

4.  Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.

Authors:  Hironao Hozumi; Noriyuki Enomoto; Yoshiyuki Oyama; Masato Kono; Tomoyuki Fujisawa; Naoki Inui; Yutaro Nakamura; Takafumi Suda
Journal:  Lung       Date:  2016-02-12       Impact factor: 2.584

5.  Lung involvement in "stable" undifferentiated connective tissue diseases: a rheumatology perspective.

Authors:  Antonella Riccardi; Rosaria Irace; Ilaria Di Stefano; Michele Iudici; Serena Fasano; Marialuisa Bocchino; Annalisa Capaccio; Alessandro Sanduzzi; Gabriele Valentini
Journal:  Clin Rheumatol       Date:  2017-06-08       Impact factor: 2.980

6.  Evaluation of circulating YKL-40 levels in idiopathic interstitial pneumonias.

Authors:  Nicoline M Korthagen; Coline H M van Moorsel; Pieter Zanen; Henk J Ruven; Jan C Grutters
Journal:  Lung       Date:  2014-10-02       Impact factor: 2.584

7.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

Authors:  William D Travis; Ulrich Costabel; David M Hansell; Talmadge E King; David A Lynch; Andrew G Nicholson; Christopher J Ryerson; Jay H Ryu; Moisés Selman; Athol U Wells; Jurgen Behr; Demosthenes Bouros; Kevin K Brown; Thomas V Colby; Harold R Collard; Carlos Robalo Cordeiro; Vincent Cottin; Bruno Crestani; Marjolein Drent; Rosalind F Dudden; Jim Egan; Kevin Flaherty; Cory Hogaboam; Yoshikazu Inoue; Takeshi Johkoh; Dong Soon Kim; Masanori Kitaichi; James Loyd; Fernando J Martinez; Jeffrey Myers; Shandra Protzko; Ganesh Raghu; Luca Richeldi; Nicola Sverzellati; Jeffrey Swigris; Dominique Valeyre
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

8.  Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.

Authors:  Hironao Hozumi; Noriyuki Enomoto; Masato Kono; Tomoyuki Fujisawa; Naoki Inui; Yutaro Nakamura; Hiromitsu Sumikawa; Takeshi Johkoh; Ran Nakashima; Yoshitaka Imura; Tsuneyo Mimori; Takafumi Suda
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

9.  Predictors of mortality in patients with interstitial lung disease treated with corticosteroids: results from a cohort study.

Authors:  Kiyoshi Migita; Toru Arai; Yuka Jiuchi; Yasumori Izumi; Nozomi Iwanaga; Chieko Kawahara; Eiichi Suematsu; Tomoya Miyamura; Hiroshi Tsutani; Yojiro Kawabe; Ryutaro Matsumura; Shunsuke Mori; Shiro Ohshima; Shigeru Yoshizawa; Yasuo Suenaga; Fumitaka Ogushi; Masaharu Kawabata; Hiroshi Furukawa; Toshihiro Matsui; Seiji Bito; Shigeto Tohma
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

10.  Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema.

Authors:  Argyris Tzouvelekis; George Zacharis; Anastasia Oikonomou; Dimitrios Mikroulis; George Margaritopoulos; Anastasios Koutsopoulos; Antonis Antoniadis; Andreas Koulelidis; Paschalis Steiropoulos; Panagiotis Boglou; Matina Bakali; Marios Froudarakis; Demosthenes Bouros
Journal:  BMC Pulm Med       Date:  2013-05-22       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.